Share this post on:

Product Name :
Sitagliptin Tartrate

Search keywords :
Sitagliptin

drugId :
null

Target Vo:
Dipeptidyl peptidase IV

Target Vo Short Name :
DPP4

Moa_Name:
Dipeptidyl peptidase IV inhibitors

First Approval Country :
EU

First Approval Date Filter:
2020

Origin Company_Name :
Heumann Pharma GmbH & Co Generica KG

Active Company_Name :
Ain Shams University

Active Indication_Name:
Metabolic Dysfunction-Associated Steatotic Liver Disease

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
p53 Rabbit mAb Purity
MEK1/2 Rabbit mAb Protocol
Smad2/3 Antibody: Smad2/3 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 52 kDa, targeting to Smad2/3. It can be used for WB,ICC/IF,FC,IP,ChIP assays with tag free, in the background of Human, Mouse, Rat.

Share this post on:

Author: Interleukin Related